Author

Alberto Odio

Observed names: A Odio, A. Odio, Alberto J. Odio, Odio, Alberto

Institution: Adventist Health Simi Valley

Observed institutions: Adventist Health Simi Valley, Heritage Medical Research Institute

OpenAlex ID: A5082700378

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

2018 · Adrian F Hernandez, Jennifer B Green, et al. · The Lancet · 1,823

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

2019 · Michael R McClung, Michelle L O'Donoghue, et al. · The Lancet Diabetes & Endocrinology · 168

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection

2023 · Matthew D. Sims, Sahil Khanna, et al. · JAMA Network Open · 83

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

2024 · Heather L Platt, Christopher Bruno, et al. · The Lancet Infectious Diseases · 63

Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial

2013 · Sydney Bonnick, Tobias De Villiers, et al. · The Journal of Clinical Endocrinology & Metabolism · 59

The incidence of acute rheumatic fever in a suburban area of Los Angeles. A ten-year study.

1986 · A Odio · PubMed · 16

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

2024 · Colleen S. Kraft, Matthew Sims, et al. · Infectious Diseases and Therapy · 9

The Treatment of Streptococcal Pharyngitis

1987 · Alberto Odio · JAMA · 5

OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate– a Randomized Placebo-Controlled Trial

2013 · S. Palacios, S. Bonnick, et al. · Annals of the Rheumatic Diseases · 1

Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate- a randomized placebo-controlled trial

2013 · Roland Chapurlat, Villiers Tobias De, et al. · Bone Abstracts · 1

Testing for Streptococcal Pharyngitis

1986 · Alberto Odio · JAMA · 1

Diagnosis and Treatment of Streptococcal Pharyngitis

1985 · Alberto Odio · JAMA · 1

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

2024 · Colleen S. Kraft, Matthew Sims, et al. · Infectious Diseases and Therapy

Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI

2023 · Matthew Sims, Charles Berenson, et al. · Antimicrobial Stewardship & Healthcare Epidemiology

Works count: 15

Citation count: 2,230

H-index: 7

I10-index: 6